Exagen (XGN) has disclosed a new risk, in the Regulation category.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Exagen faces potential business risks stemming from ongoing legal proceedings, as outlined in their recent disclosures. These legal challenges could impact the company’s financial stability and operational efficiency. Stakeholders should be aware of the uncertainties associated with litigation outcomes, which may lead to unforeseen expenses or liabilities. The resolution of these proceedings is crucial for Exagen to maintain its market position and investor confidence.
The average XGN stock price target is $10.83, implying 28.93% upside potential.
To learn more about Exagen’s risk factors, click here.